Every year, DEBRA International launches calls for EB researchers anywhere in the world to submit applications for funding to support their EB research projects in areas that have been determined to be priorities by DEBRA groups and the international EB Community.


Currently accepting applications on research projects that meet our current four research priorities


Opening date: 31 January 2020

Submission deadline: 6 April 2020 at 15:00 GMT

Current research priorities

1. Improving understanding of EB biology to create new concepts for diagnosis and treatment.

2. Developing disease-modifying and curative therapies.

3. Preventing and curing severe disease consequences: chronic wounds, fibrosis, and cancer.

4. Improving clinical care and symptom relief through research.

Application process

  • One-stage process.


  • Meets one of the priority research areas.

  • Duration of 6 months to 3 years.

  • Funding requests not expected to exceed €90K per year. Exceptions depend on justification of expenses in the application and funding availability.

  • Currency may be in USD, EUR, or GBP - contracts are issued in one of those three currencies.


Review process

  • Proposals will be reviewed by external reviewers and members of an expert panel on 29 June 2020. 

  • Final funding decisions will be at the discretion of the funding organisations. Funding decisions are anticipated to be made in July and August 2020 (TBC).


  • Proposals for co-funding with other organisations are welcome.

  • Generic technology development costs not closely related to a specific EB therapeutic approach will not be funded.

  • If in doubt about the eligibility of your application, contact Dr. Gaston Sendin at, before applying.